Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.Read More
Grace Linton, RA, AIA, LEED AP BD+C
Grace Linton has delivered projects in North America, Europe and Asia, covering a wide range of facility types, including monoclonal antibodies, vaccines, blood fractionation, active pharmaceutical ingredients, oral solid dosage, medical devices, fill finish, oligonucleotides and cell and gene therapies. As a lead process architect for designing Current Good Manufacturing Practice (CGMP) biopharmaceutical facilities, Linton is responsible for integrating the client’s goals and programming criteria, regulatory requirements and building codes and standards into a cohesive facility concept.
Linton’s design acumen is evident in design workshops where she draws from her broad knowledge in process, equipment and technology, CGMP operations and flows, and building systems to deftly construct a facility concept. Her dynamic design approach is supplemented by real-time 3-D modeling that serves as a communication tool for visualizing and exploring spatial concepts. Linton has a Bachelor of Arts in architecture from Washington University in St. Louis.